Show simple item record

dc.contributor.authorGoniotaki, D
dc.contributor.authorTamagnini, F
dc.contributor.authorBiasetti, L
dc.contributor.authorRumpf, S
dc.contributor.authorTroakes, C
dc.contributor.authorPollack, SJ
dc.contributor.authorUkwesa, S
dc.contributor.authorSun, H
dc.contributor.authorKraev, I
dc.contributor.authorSerpell, LC
dc.contributor.authorNoble, W
dc.contributor.authorStaras, K
dc.contributor.authorHanger, DP
dc.date.accessioned2024-07-17T08:52:54Z
dc.date.issued2024-07-12
dc.date.updated2024-07-15T07:22:36Z
dc.description.abstractINTRODUCTION In tauopathies, altered tau processing correlates with impairments in synaptic density and function. Changes in hyperpolarization-activated cyclic nucleotide-gated (HCN) channels contribute to disease-associated abnormalities in multiple neurodegenerative diseases. METHODS To investigate the link between tau and HCN channels, we performed histological, biochemical, ultrastructural, and functional analyses of hippocampal tissues from Alzheimer's disease (AD), age-matched controls, Tau35 mice, and/or Tau35 primary hippocampal neurons. RESULTS Expression of specific HCN channels is elevated in post mortem AD hippocampus. Tau35 mice develop progressive abnormalities including increased phosphorylated tau, enhanced HCN channel expression, decreased dendritic branching, reduced synapse density, and vesicle clustering defects. Tau35 primary neurons show increased HCN channel expression enhanced hyperpolarization-induced membrane voltage “sag” and changes in the frequency and kinetics of spontaneous excitatory postsynaptic currents. DISCUSSION Our findings are consistent with a model in which pathological changes in tauopathies impact HCN channels to drive network-wide structural and functional synaptic deficits. Highlights Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are functionally linked to the development of tauopathy. Expression of specific HCN channels is elevated in the hippocampus in Alzheimer's disease and the Tau35 mouse model of tauopathy. Increased expression of HCN channels in Tau35 mice is accompanied by hyperpolarization-induced membrane voltage “sag” demonstrating a detrimental effect of tau abnormalities on HCN channel function. Tau35 expression alters synaptic organization, causing a loosened vesicle clustering phenotype in Tau35 mice.en_GB
dc.description.sponsorshipBiotechnology and Biological Sciences Research Council (BBSRC)en_GB
dc.description.sponsorshipAlzheimer’s Societyen_GB
dc.description.sponsorshipAlzheimer’s Research UKen_GB
dc.identifier.citationPublished online 12 July 2024en_GB
dc.identifier.doihttps://doi.org/10.1002/alz.14074
dc.identifier.grantnumberBB/K019015/1en_GB
dc.identifier.grantnumberBB/S00310X/1en_GB
dc.identifier.urihttp://hdl.handle.net/10871/136737
dc.identifierORCID: 0000-0002-7898-4295 (Noble, Wendy)
dc.language.isoenen_GB
dc.publisherWiley / Alzheimer’s Association.en_GB
dc.rights© 2024 The Author(s). Alzheimer’s & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer’s Association. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.en_GB
dc.subjectdementiaen_GB
dc.subjecthyperpolarization-activated cyclic nucleotide-gated channelsen_GB
dc.subjectneurodegenerationen_GB
dc.subjectsag voltageen_GB
dc.subjectsynapsesen_GB
dc.subjecttauopathiesen_GB
dc.titleTau‐mediated synaptic dysfunction is coupled with HCN channelopathyen_GB
dc.typeArticleen_GB
dc.date.available2024-07-17T08:52:54Z
dc.identifier.issn1552-5260
dc.descriptionThis is the final version. Available on open access from Wiley via the DOI in this record. en_GB
dc.identifier.eissn1552-5279
dc.identifier.journalAlzheimer's & Dementiaen_GB
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2024-05-25
dcterms.dateSubmitted2024-01-29
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2024-05-25
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2024-07-17T08:41:59Z
refterms.versionFCDVoR
refterms.dateFOA2024-07-17T08:54:05Z
refterms.panelAen_GB
refterms.dateFirstOnline2024-07-12
exeter.rights-retention-statementYes


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2024 The Author(s). Alzheimer’s & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer’s Association. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided
the original work is properly cited.
Except where otherwise noted, this item's licence is described as © 2024 The Author(s). Alzheimer’s & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer’s Association. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.